MAPT and Alzheimer disease: To verify whether the DDB-mediated improvement in cognitive function of 3 × Tg-AD mice can be attributed to its effect to attenuate APP and tau pathology, the levels of different forms of APP- and tau-related protein in the hippocampus and cortex of mice were determined by Western blot.